Sunday, July 5, 2026
ADVT 
International

US reaches H-1B visa cap for FY24

Darpan News Desk IANS, 15 Dec, 2023 11:38 AM
  • US reaches H-1B visa cap for FY24

Washington, Dec 15 (IANS) The US Citizenship and Immigration Services (USCIS) said it has received a sufficient number of petitions to reach the congressionally-mandated cap for the most-coveted H-1B visa for the fiscal year 2024.

This includes the 65,000 H-1B visa regular cap as well as the 20,000 H-1B visa US advanced degree exemption, commonly referred to as the master’s cap.

The non-immigrant work visa allows US employers to hire foreign workers with specialised skills to work in the country for a specific period of time.

In a statement on Wednesday, the USCIS said will send notices to registrants who were not selected for the visa programme, through their online accounts over the next few days.

However, the the federal agency said will continue to accept and process petitions exempt from the cap.

"Petitions filed for current H-1B workers who have been counted previously against the cap, and who still retain their cap number, are exempt from the FY 2024 H-1B cap," the USCIS said.

An estimated 75 per cent of the H-1B visa granted in a year are known to go to workers from India, hired by some of the largest US tech giant such as Amazon, Microsoft, Google and Facebook as well as IT services behemoths like Infosys, TCS and Wipro.

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report